• Aaseth J, Smith-Kielland A, Thomassen Y. Selenium, alcohol and liver diseases. Ann. Clin. Res. 18: 43-47 (1986).

• Al Hussami O, Godinot C, Monier JM, Trepo C, Monier JC. Demonstration of anti-mitochondria antibodies by ELISA. Comparison with the indirect immunofluorescence technique on organ sections. J. Clin. Lab. Immunol. 21: 195-199 (1986).

• Al-Aghbar MN, Alexander GJ, Neuberger J, Nouri-Aria KT, Eddleston AL, Williams R. The effect of prednisolone in vitro on immunoglobulin production in primary biliary cirrhosis. Clin. Exp. Immunol. 63: 663-670 (1986). *

• Al-Aghbar MN, Alexander GJ, Nouri-Aria KT, Neuberger J, Eddleston AL, Williams R. In vitro effect of cyclosporin A on immunoglobulin production and concanavalin A induced suppression in primary biliary cirrhosis. Gut 27: 317-323 (1986). *

• Alberti-Flor JJ, de Medina M, Jeffers L, Schultz DR, Schiff ER. Elevated levels of immunoglobulins and immune complexes in the bile of patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 81: 325-328 (1986).

• Alderuccio F, Toh BH, Barnett AJ, Pedersen JS. Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identity with the 72,000 dalton autoantigen in primary biliary cirrhosis. J. Immunol. 137: 1855-1859 (1986).

• Anderson KE, Simionatto CS, Drummond GS, Kappas A. Disposition of tin-protoporphyrin and suppression of hyperbilirubinemia in humans. Clin. Pharmacol. Ther. 39: 510-520 (1986).

• Arnaud-Battandier F, Cerf-Bensussan N, Amsellem R, Schmitz J. Increased HLA-DR expression by enterocytes in children with celiac disease. Gastroenterology 91: 1206-1212 (1986).

• Atluru D, Lianos EA, Goodwin JS. Arachidonic acid inhibits 5-lipoxygenase in human T cells. Biochem. Biophys. Res. Commun. 135: 670-676 (1986).

• Avigan MI, Adamson G, Hoofnagle JH, Jones EA. The in vitro production of antibodies to mitochondrial antigens by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Hepatology 6: 999-1004 (1986).

• Barbatis C, Morton J, Woods JC, Burns J, Bradley J, McGee JO. Disorganisation of intermediate filament structure in alcoholic and other liver diseases. Gut 27: 765-770 (1986). *

• Barnes S, Waldrop R, Crenshaw J, King RJ, Taylor KB. Evidence for an ordered reaction mechanism for bile salt: 3'phosphoadenosine-5'-phosphosulfate: sulfotransferase from rhesus monkey liver that catalyzes the sulfation of the hepatotoxin glycolithocholate. J. Lipid Res. 27: 1111-1123 (1986). *

• Barr GD, Shale DJ, Jewell DP. Ulcerative colitis and sarcoidosis. Postgrad. Med. J. 62: 341-345 (1986). *

• Behr W, Barnert J. Adult celiac disease and primary biliary cirrhosis. Am. J. Gastroenterol. 81: 796-799 (1986).

• Bell J, Rassenti L, Smoot S, Smith K, Newby C, Hohlfeld R, Toyka K, McDevitt H, Steinman L. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet 1: 1058-1060 (1986).

• Belloli G, Bedogni L, Musi L, Mercurella A, Colombo B. Surgery of malformations of extrahepatic bile ducts in childhood. Pediatr. Med. Chir. 8: 647-655 (1986).

• Berg PA, Klein R. Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9. Klin. Wochenschr. 64: 897-909 (1986).

• Berg PA, Klein R, Lindenborn-Fotinos J. Antimitochondrial antibodies in primary biliary cirrhosis. J. Hepatol. 2: 123-131 (1986).

• Biemond I, Burnham WR, D'Amaro J, Langman MJ. HLA-A and -B antigens in inflammatory bowel disease. Gut 27: 934-941 (1986). *

• Bohme J, Carlsson B, Wallin J, Moller E, Persson B, Peterson PA, Rask L. Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J. Immunol. 137: 941-947 (1986).

• Boitard C, Debray-Sachs M, Bach JF. Autoimmune disorders in diabetes. Adv. Nephrol. Necker Hosp. 15: 281-305 (1986).

• Brickman CM, Tsokos GC, Balow JE, Lawley TJ, Santaella M, Hammer CH, Frank MM. Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J. Allergy Clin. Immunol. 77: 749-757 (1986).

• Brodin MB. Inflammatory bowel disease and isotretinoin. J. Am. Acad. Dermatol. 14: 843 (1986).

• Burks AW Jr, Steele RW. Selective IgA deficiency. Ann. Allergy 57: 3-13 (1986).

• Burns DG. Smoking in inflammatory bowel disease and the irritable bowel syndrome. S. Afr. Med. J. 69: 232-233 (1986).

• Calin A. Seronegative spondyloarthritides. Med. Clin. North Am. 70: 323-336 (1986).

• Carstensen H, Nilsson KO, Nettelblad SC, Cederlund CG, Hildell J. Common bile duct obstruction due to an intraluminal mass of candidiasis in a previously healthy child. Pediatrics 77: 858-861 (1986).

• Catassi C, Guerrieri A, Natalini G, Busco F, Giorgi PL. Macroamylasaemia and selective IgA deficiency. Arch. Dis. Child. 61: 704-706 (1986). *

• Chapman RW, Cottone M, Selby WS, Shepherd HA, Sherlock S, Jewell DP. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut 27: 86-91 (1986). *

• Chazouilleres O, Andreani T, Legendre C, Poupon R, Darnis F. Nodular regenerative hyperplasia of the liver and primary biliary cirrhosis. A fortuitous association? Gastroenterol. Clin. Biol. 10: 764-766 (1986).

• Chen CC, Chang PY, Chen CL. Refractory cholangitis after Kasai's operation caused by candidiasis: a case report. J. Pediatr. Surg. 21: 736-737 (1986).

• Chesner IM, Muller S, Newman J. Ulcerative colitis complicated by Budd-Chiari syndrome. Gut 27: 1096-1100 (1986). *

• Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA. Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J. Clin. Microbiol. 24: 357-363 (1986). *

• Clapp DW, Kleiman MB, Reynolds JK, Allen SD. Pasteurella multocida meningitis in infancy. An avoidable infection. Am. J. Dis. Child. 140: 444-446 (1986).

• Clements D, Rhodes JM, Elias E. Severe bile duct lesions without biochemical evidence of cholestasis in a case of sclerosing cholangitis. J. Hepatol. 3: 72-74 (1986).

• Cohen BI, Hofmann AF, Mosbach EH, Stenger RJ, Rothschild MA, Hagey LR, Yoon YB. Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit. Gastroenterology 91: 189-197 (1986).

• Cohen N, Brautbar C, Font MP, Dausset J, Cohen D. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics 23: 84-89 (1986).

• Colaco CB, Awad J, Festenstein H, Fielder A, Batchelor JR, Alonso A, McCloskey D, Shipley M, Corbett M, Roitt IM. HLA frequency and haplotype analysis in a family study of adult onset rheumatoid arthritis. Dis. Markers 4: 99-102 (1986).

• Colston K, Cleeve HJ. Effect of triiodothyronine on intestinal and kidney isoenzymes of alkaline phosphatase and on vitamin D metabolism in adult female rats. Comp. Biochem. Physiol. B. 83: 681-684 (1986).

• Colucci G, Schaffner F, Paronetto F. In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis. Clin. Immunol. Immunopathol. 41: 35-42 (1986).

• Cottier H, Hassig A. Immunoglobulin in chronic inflammatory diseases. Vox. Sang. 51 Suppl. 2: 39-43 (1986).

• Czinn SJ, Lamm ME. Selective chemotaxis of subsets of B lymphocytes from gut-associated lymphoid tissue and its implications for the recruitment of mucosal plasma cells. J. Immunol. 136: 3607-3611 (1986).

• Dabaghi RE, Lester R. Primary biliary cirrhosis. Am. Fam. Physician 33: 155-165 (1986).

• Dahlgren UI, Ahlstedt S, Hanson LA. Hepatic production of biliary IgM in the rat. Scand. J. Immunol. 24: 615-619 (1986).

• de Freitas LA, Chevallier M, Louis D, Grimaud JA. Human extrahepatic biliary atresia: portal connective tissue activation related to ductular proliferation. Liver 6: 253-261 (1986).

• de Jongh BM, Westedt ML, de Vries RR, Valkenburg HA, Cats A. Genetic heterogeneity of rheumatoid arthritis. Dis. Markers 4: 29-33 (1986).

• Deen KC, Sweet RW. Murine mammary tumor virus pol-related sequences in human DNA: characterization and sequence comparison with the complete murine mammary tumor virus pol gene. J. Virol. 57: 422-432 (1986). *

• Delgado-Escueta AV, White R, Greenberg DA, Treiman LJ. Looking for epilepsy genes: clinical and molecular genetic studies. Adv. Neurol. 44: 77-95 (1986).

• Diederichsen H, Riisom K, Andersen I, Hage E. Antibodies to isolated hepatocytes in chronic active liver disease. Identification and diagnostic significance of bile canalicular antibodies. Scand. J. Gastroenterol. 21: 146-150 (1986).

• Dikengil A, Siskind BN, Morse SS, Swedlund A, Bober-Sorcinelli KE, Burrell MI. Sclerosing cholangitis from intraarterial floxuridine. J. Clin. Gastroenterol. 8: 690-693 (1986).

• DiPalma JA, Strobel CT, Farrow JG. Primary sclerosing cholangitis associated with hyperimmunoglobulin M immunodeficiency (dysgammaglobulinemia). Gastroenterology 91: 464-468 (1986).

• Dooley DP, Mills GM, Spiva DA. Immune thrombocytopenia and ulcerative colitis. South. Med. J. 79: 1044-1045 (1986).

• Egawa S, Hiwatashi N. Natural killer cell activity in patients with inflammatory bowel disease. J. Clin. Lab. Immunol. 20: 187-192 (1986).

• Elson CO, Kagnoff MF, Fiocchi C, Befus AD, Targan S. Intestinal immunity and inflammation: recent progress. Gastroenterology 91: 746-768 (1986).

• Eriksson S, Zettervall O. The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis. J. Hepatol. 2: 370-378 (1986).

• Evans GW. Zinc and its deficiency diseases. Clin. Physiol. Biochem. 4: 94-98 (1986).

• Evans RA. The aetiology of Dupuytren's disease. Br. J. Hosp. Med. 36: 198-199 (1986).

• Everson GT, Polokoff MA. HepG2. A human hepatoblastoma cell line exhibiting defects in bile acid synthesis and conjugation. J. Biol. Chem. 261: 2197-2201 (1986). *

• Farid NR, Thompson C. HLA and autoimmune endocrine disease 1985. Mol. Biol. Med. 3: 85-97 (1986).

• Farrell MK, Balistreri WF. Parenteral nutrition and hepatobiliary dysfunction. Clin. Perinatol. 13: 197-212 (1986).

• Fawaz F, Belding RC. Primary sclerosing cholangitis. A case associated with diabetes mellitus. W. V. Med. J. 82: 331-332 (1986).

• Feist D. Liver cirrhosis in childhood - etiology, diagnosis and conservative therapy. Wien. Klin. Wochenschr. 98: 547-551 (1986).

• Ferguson MM, MacFadyen EE. Orofacial granulomatosis - a 10 year review. Ann. Acad. Med. Singapore 15: 370-377 (1986).

• Festenstein H, Awad J, Hitman GA, Cutbush S, Groves AV, Cassell P, Ollier W, Sachs JA. New HLA DNA polymorphisms associated with autoimmune diseases. Nature 322: 64-67 (1986). *

• Field LL, Fothergill-Payne C, Bertrams J, Baur MP. HLA-DR effects in a large German IDDM dataset. Genet. Epidemiol. Suppl. 1: 323-328 (1986).

• Fielding JF. The relative risk of inflammatory bowel disease among parents and siblings of Crohn's disease patients. J. Clin. Gastroenterol. 8: 655-657 (1986).

• Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Adaptation to methionine excess. J. Biol. Chem. 261: 1582-1587 (1986). *

• Foidart JM, Hunt J, Lapiere CM, Nusgens B, De Rycker C, Bruwier M, Lambotte R, Bernard A, Mahieu P. Antibodies to laminin in preeclampsia. Kidney Int. 29: 1050-1057 (1986).

• Fonseca V, Epstein O, Katrak A, Junglee D, Mikhailidis DP, McIntyre N, Dandona P. Serum immunoreactive trypsin and pancreatic lipase in primary biliary cirrhosis. J. Clin. Pathol. 39: 638-640 (1986). *

• Fraser JR, Engstrom-Laurent A, Nyberg A, Laurent TC. Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis. J. Lab. Clin. Med. 107: 79-85 (1986).

• Frebourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, Bourreille J. Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology 6: 392-395 (1986).

• Friedrich K, Henning H. Value of laparoscopy in the diagnosis of chronic nonsuppurative destructive cholangitis. Z. Gastroenterol. 24: 364-374 (1986).

• Fujiwara R, Tobe K, Nagashima H. Studies on cellular immunity against bile proteins in primary biliary cirrhosis by the leukocyte migration inhibition test (microdroplet method). Acta Med. Okayama 40: 17-25 (1986).

• Geczy AF, McGuigan LE, Sullivan JS, Edmonds JP. Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis. J. Exp. Med. 164: 932-937 (1986). *

• Ghadiminejad I, Baum H. Discrimination between M2 and M4 antimitochondrial antibodies in primary biliary cirrhosis. Biosci. Rep. 6: 1049-1056 (1986).

• Gibson PR, Jewell DP. Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma. Natural killer cells and their activity. Gastroenterology 90: 12-19 (1986).

• Giustina TA, Stewart JC, Ellis CN, Regezi JA, Annesley T, Woo TY, Voorhees JJ. Topical application of isotretinoin gel improves oral lichen planus. A double-blind study. Arch. Dermatol. 122: 534-536 (1986).

• Goksu N, Ozsoylu S. Hepatic and serum levels of zinc, copper, and magnesium in childhood cirrhosis. J. Pediatr. Gastroenterol. Nutr. 5: 459-462 (1986).

• Gomez RL, Griffin JW Jr, Squires JE. Prolonged relief of intractable pruritus in primary sclerosing cholangitis by plasmapheresis. J. Clin. Gastroenterol. 8: 301-303 (1986).

• Goodwin JS, Atluru D. Mechanism of action of glucocorticoid-induced immunoglobulin production: role of lipoxygenase metabolites of arachidonic acid. J. Immunol. 136: 3455-3460 (1986).

• Goodwin JS, Atluru D, Sierakowski S, Lianos EA. Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4. J. Clin. Invest. 77: 1244-1250 (1986). *

• Gordon RD, Shaw BW Jr, Iwatsuki S, Esquivel CO, Starzl TE. Indications for liver transplantation in the cyclosporine era. Surg. Clin. North Am. 66: 541-556 (1986).

• Grennan DM, Sanders PA, Dyer PA, Harris R. HLA haplotype sharing by siblings with rheumatoid arthritis: evidence for genetic heterogeneity. Ann. Rheum. Dis. 45: 126-129 (1986). *

• Grennan DM, Sanders PA, Thomson W, Dyer PA. Rheumatoid arthritis: inheritance and association with other autoimmune diseases. Dis. Markers 4: 157-162 (1986).

• Grieco A, Caputo S, Bertoli A, Caradonna P, Greco AV. Megaloblastic anaemia due to sulphasalazine responding to drug withdrawal alone. Postgrad. Med. J. 62: 307-308 (1986). *

• Grijm R, Huibregtse K, Bartelsman J, Mathus-Vliegen EM, Dekker W, Tytgat GN. Therapeutic investigations in primary sclerosing cholangitis. Dig. Dis. Sci. 31: 792-798 (1986).

• Gupta S, Saverymuttu SH, Marsh JC, Hodgson HJ, Chadwick VS. Immune thrombocytopenic purpura, neutropenia and sclerosing cholangitis associated with ulcerative colitis in an adult. Clin. Lab. Haematol. 8: 67-69 (1986).

• Hagglof B, Holmgren G, Holmlund G, Lindblom B, Olaisen B, Teisberg P. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden. Hum. Hered. 36: 201-212 (1986).

• Hall S, Czaja AJ, Kaufman DK, Markowitz H, Ginsburg WW. How lupoid is lupoid hepatitis? J. Rheumatol. 13: 95-98 (1986).

• Hals J, Dodgson MS, Skulberg A, Kenna JG. Halothane-associated liver damage and renal failure in a young child. Acta Anaesthesiol. Scand. 30: 651-655 (1986).

• Hankin FM, Eckenrode J, Louis DS. Oestrogen and progesterone hormone receptors in Dupuytren's disease. J. Hand Surg. [Br.] 11: 463-464 (1986).

• Hannuksela M, Lahti A. Peroral challenge tests with food additives in urticaria and atopic dermatitis. Int. J. Dermatol. 25: 178-180 (1986).

• Haq AU. 1,25-Dihydroxyvitamin D3 (calcitriol) suppresses IL-2 induced murine thymocyte proliferation. Thymus 8: 295-306 (1986).

• Hendrick AM, Mitchison HC, Bird AG, James OF. Paraproteins in primary biliary cirrhosis. Q. J. Med. 60: 681-684 (1986).

• Hirata I, Austin LL, Blackwell WH, Weber JR, Dobbins WO 3rd. Immunoelectron microscopic localization of HLA-DR antigen in control small intestine and colon and in inflammatory bowel disease. Dig. Dis. Sci. 31: 1317-1330 (1986).

• Hirata I, Berrebi G, Austin LL, Keren DF, Dobbins WO 3rd. Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and in inflammatory bowel disease. Dig. Dis. Sci. 31: 593-603 (1986).

• Hirose S, Ueda G, Noguchi K, Okada T, Sekigawa I, Sato H, Shirai T. Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice. Eur. J. Immunol. 16: 1631-1633 (1986).

• Hoffmann R, Germann EJ, Schmidt U, Jenss H. Primary biliary liver cirrhosis and granulomatous pulmonary infiltrates. Schweiz. Med. Wochenschr. 116: 1098-1102 (1986).

• Hollanders D. Sensorineural deafness - a new complication of ulcerative colitis? Postgrad. Med. J. 62: 753-755 (1986). *

• Hollman AS, Morley P, Burt AD, Davidson JK. Biliary tract dilatation in acquired immune deficiency syndrome. Eur. J. Radiol. 6: 309-310 (1986).

• Holman RT. Control of polyunsaturated acids in tissue lipids. J. Am. Coll. Nutr. 5: 183-211 (1986).

• Holt KM, Miyai K, Chojkier M. Asymptomatic primary biliary cirrhosis in an old man. J. Clin. Gastroenterol. 8: 203-206 (1986).

• Honore P, Meurisse M, Wetz P. Primary sclerosing cholangitis. Rev. Med. Liege. 41: 205-208 (1986).

• Hoofnagle JH, Davis GL, Schafer DF, Peters M, Avigan MI, Pappas SC, Hanson RG, Minuk GY, Dusheiko GM, Campbell G, et al. Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 91: 1327-1334 (1986).

• Hoult JR. Pharmacological and biochemical actions of sulphasalazine. Drugs 32 Suppl. 1: 18-26 (1986).

• Howell MD, Austin RK, Kelleher D, Nepom GT, Kagnoff MF. An HLA-D region restriction fragment length polymorphism associated with celiac disease. J. Exp. Med. 164: 333-338 (1986). *

• Illescas FF, Braun SD, Cohan RH, Bowie JD, Dunnick NR. Ultrasonically guided percutaneous transhepatic transcholecystocholangiography in the nondilated biliary tree. Gastrointest. Radiol. 11: 77-80 (1986).

• Inoue T, Okumura Y, Shirama M, Ishibashi H, Kashiwagi S, Okubo H. Selective partial IgM deficiency: functional assessment of T and B lymphocytes in vitro. J. Clin. Immunol. 6: 130-135 (1986).

• Irani M, Truong LD. Candidiasis of the extrahepatic biliary tract. Arch. Pathol. Lab. Med. 110: 1087-1090 (1986).

• James DG, Vella M. Hepatic granulomas. Sarcoidosis 3: 30-33 (1986).

• James SP, Jones EA, Schafer DF, Hoofnagle JH, Varma RR, Strober W. Selective immunoglobulin A deficiency associated with primary biliary cirrhosis in a family with liver disease. Gastroenterology 90: 283-288 (1986).

• Jansen PL, Peters WH, Janssens AR. Clinical value of serum bilirubin subfractionation by high-performance liquid chromatography and conventional methods in patients with primary biliary cirrhosis. J. Hepatol. 2: 485-494 (1986).

• Jaraquemada D, Ollier W, Awad J, Young A, Festenstein H. HLA and rheumatoid arthritis: susceptibility or severity? Dis. Markers 4: 43-53 (1986).

• Javitt NB, Kok E, Carubbi F, Blizzard T, Gut M, Byon CY. Bile acid synthesis. Metabolism of 3 beta-hydroxy-5-cholenoic acid to chenodeoxycholic acid. J. Biol. Chem. 261: 12486-12489 (1986). *

• Johnson DA, Cattau EL Jr, Hancock JE. Pediatric primary sclerosing cholangitis. Dig. Dis. Sci. 31: 773-777 (1986). *

• Jorde R, Rekvig OP, Bostad L. A follow-up study of 68 patients with anti-mitochondrial antibodies (AMA). Acta Med. Scand. 220: 241-247 (1986).

• Juppner H, Rittinghaus EF, Ahlgrimm M, Burdelski M, Dralle H. C-terminal PTH (70-84) after biliary ligation in rats: implications for the diagnostic importance in hepatobiliary disease. Biochem. Biophys. Res. Commun. 139: 633-636 (1986).

• Kahn E, Daum F, Markowitz J, Teichberg S, Duffy L, Harper R, Aiges H. Nonsyndromatic paucity of interlobular bile ducts: light and electron microscopic evaluation of sequential liver biopsies in early childhood. Hepatology 6: 890-901 (1986).

• Kakumu S, Fukui K, Yoshioka K, Murakami H. Suppression of immunoglobulin synthesis by activated B cells in chronic active liver diseases and primary biliary cirrhosis. Gastroenterol. Jpn. 21: 23-29 (1986).

• Kaplan MM, Alling DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, Elta GH, Glick KA, Eagen KA. A prospective trial of colchicine for primary biliary cirrhosis. N. Engl. J. Med. 315: 1448-1454 (1986).

• Kaplowitz N, Aw TY, Simon FR, Stolz A. Drug-induced hepatotoxicity. Ann. Intern. Med. 104: 826-839 (1986).

• Kelleher D, Jackson J, Weir DG, Feighery C. Primary biliary cirrhosis: an underestimated disorder? Ir. J. Med. Sci. 155: 190-193 (1986).

• Kenny RP, Czaja AJ, Ludwig J, Dickson ER. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig. Dis. Sci. 31: 705-711 (1986).

• Khan MA, Khan MK. HLA studies in familial and sporadic rheumatoid arthritis. Dis. Markers 4: 67-76 (1986).

• Khan MA, Khan MK. Analysis of genetic susceptibility to familial rheumatoid arthritis. Dis. Markers 4: 77-84 (1986).

• Kijlstra A, Luyendijk L, van der Gaag R, van Kregten E, Linssen A, Willers JM. IgG and IgA immune response against Klebsiella in HLA-B27-associated anterior uveitis. Br. J. Ophthalmol. 70: 85-88 (1986). *

• Kilby AE, Krawitt EL. Thymosin effects on immunoglobulin synthesis and suppressor T cell activity in normal subjects and patients with primary biliary cirrhosis. Int. J. Immunopharmacol. 8: 119-124 (1986).

• Kirby DF, Blei AT, Rosen ST, Vogelzang RL, Neiman HL. Primary sclerosing cholangitis in the presence of a lupus anticoagulant. Am. J. Med. 81: 1077-1080 (1986).

• Kligman AM, Greaves MW, Steinman H. Water-induced itching without cutaneous signs. Aquagenic pruritus. Arch. Dermatol. 122: 183-186 (1986).

• Knight RE, Bourne AJ, Newton M, Black A, Wilson P, Lawson MJ. Neurologic syndrome associated with low levels of vitamin E in primary biliary cirrhosis. Gastroenterology 91: 209-211 (1986).

• Knoflach P. Etiology and pathogenesis of Crohn disease and ulcerative colitis. Wien. Klin. Wochenschr. 98: 754-758 (1986).

• Koelma IA, Nap M, Huitema S, Krom RA, Houthoff HJ. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters. Arch. Pathol. Lab. Med. 110: 1035-1040 (1986).

• Konikoff F, Theodor E. Painful muscle cramps. A symptom of liver cirrhosis? J. Clin. Gastroenterol. 8: 669-672 (1986).

• Krom RA. Liver transplantation at the Mayo Clinic. Mayo Clin. Proc. 61: 278-282 (1986).

• Kunze KD, Kobe E. Differential diagnosis and staging of chronic nonsuppurative destructive cholangitis in liver biopsies. Zentralbl. Allg. Pathol. 132: 223-232 (1986).

• Labat ML. Retroviruses, immunosuppression and osteopetrosis. Biomed. Pharmacother. 40: 85-90 (1986).

• LaRusso NF, Ludwig J. Primary sclerosing cholangitis. Dtsch. Med. Wochenschr. 111: 1263 (1986).

• Lashner BA, Evans AA, Kirsner JB, Hanauer SB. Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology 91: 1396-1400 (1986).

• Leickley FE, Buckley R. Variability in B cell maturation and differentiation in X-linked agammaglobulinemia. Clin. Exp. Immunol. 65: 90-99 (1986). *

• Leickly FE, Buckley RH. Development of IgA and IgG2 subclass deficiency after sulfasalazine therapy. J. Pediatr. 108: 481-482 (1986).

• Leiser A, Kadish U. Beneficial effect of colchicine in a case of sclerosing cholangitis. Am. J. Med. Sci. 291: 416-418 (1986).

• Leiss O, Meyer-Krahmer K, von Bergmann K. Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate. J. Lipid Res. 27: 213-223 (1986).

• Linssen A, Dekker-Saeys AJ, Dijkstra PF, Rothova A, Kruit PJ, Bakker M, Kijlstra A, Feltkamp TE. The use of HLA-B27 as a diagnostic and prognostic aid in acute anterior uveitis (AAU) in The Netherlands. Doc. Ophthalmol. 64: 217-223 (1986).

• Lionarons RJ, van Zoeren M, Verhagen JN, Lammers HA. HLA-B27 associated reactive spondyloarthropathies in a Dutch military hospital. Ann. Rheum. Dis. 45: 141-143 (1986). *

• Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh. Treatment of chronic diseases of the liver with catergen. Ter. Arkh. 58: 73-76 (1986).

• Lucey MR, Neuberger JM, Williams R. Primary biliary cirrhosis in men. Gut 27: 1373-1376 (1986). *

• Ludwig J, MacCarty RL, LaRusso NF, Krom RA, Wiesner RH. Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis. Hepatology 6: 560-568 (1986).

• Lundberg I, Ekdahl M, Kronevi T, Lidums V, Lundberg S. Relative hepatotoxicity of some industrial solvents after intraperitoneal injection or inhalation exposure in rats. Environ. Res. 40: 411-420 (1986).

• MacDermott RP, Nash GS, Bertovich MJ, Mohrman RF, Kodner IJ, Delacroix DL, Vaerman JP. Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease. Gastroenterology 91: 379-385 (1986).

• MacDonald MJ, Famuyiwa OO, Nwabuebo IA, Bella AF, Junaid TA, Marrari M, Duquesnoy RJ. HLA-DR associations in black type I diabetics in Nigeria. Further support for models of inheritance. Diabetes 35: 583-589 (1986).

• Maclaren NK, Riley WJ. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. J. Clin. Endocrinol. Metab. 62: 455-459 (1986).

• Maeda N, McEvoy SM, Harris HF, Huisman TH, Smithies O. Polymorphisms in the human haptoglobin gene cluster: chromosomes with multiple haptoglobin-related (Hpr) genes. Proc. Natl. Acad. Sci. U.S.A. 83: 7395-7399 (1986). *

• Maeda N, Smithies O. The evolution of multigene families: human haptoglobin genes. Annu. Rev. Genet. 20: 81-108 (1986). *

• Mangnall YF, Smythe A, Johnson AG. The ability of antacids and cholestyramine to bind bile acids: effect of pH. Scand. J. Gastroenterol. 21: 789-794 (1986).

• Mayer L, Kwan SP, Thompson C, Ko HS, Chiorazzi N, Waldmann T, Rosen F. Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N. Engl. J. Med. 314: 409-413 (1986).

• McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R. Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J. Hepatol. 3: 196-205 (1986).

• McGuigan LE, Geczy AF, Prendergast JK, Edmonds JP, Hart HH, Bashir HV. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis. Ann. Rheum. Dis. 45: 144-148 (1986).

• Mendel-Hartvig I, Frostell A, Nelson BD. Primary biliary cirrhosis: assessment of the quantitative importance of the adenine nucleotide translocator protein as a major mitochondrial antigen. Clin. Exp. Immunol. 66: 399-405 (1986). *

• Merritt RJ. Cholestasis associated with total parenteral nutrition. J. Pediatr. Gastroenterol. Nutr. 5: 9-22 (1986).

• Meryn S. Role of nutrition in acute and long-term therapy of chronic inflammatory bowel diseases. Wien. Klin. Wochenschr. 98: 774-779 (1986).

• Minuk GY, Vergalla J, Hanson RG, Hoofnagle JH, Frank MM, Jones EA. Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis. Gut 27: 324-328 (1986). *

• Mir-Madjlessi SH, Sivak MV Jr, Farmer RG. Hypereosinophilia, ulcerative colitis, sclerosing cholangitis, and bile duct carcinoma. Am. J. Gastroenterol. 81: 483-485 (1986).

• Mitchison HC, Bassendine MF, Hendrick A, Bennett MK, Bird G, Watson AJ, James OF. Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology 6: 1279-1284 (1986).

• Mizoguchi Y, Miyajima K, Sakagami Y, Yamamoto S, Morisawa S. Detection of the cholestatic factor in the liver tissue of patients with acute intrahepatic cholestasis. Ann. Allergy 56: 304-307 (1986).

• Modena V, Marengo C, Amoroso A, Rosina F, Costantini P, Bellando P, Coppo R, Rizzetto M. Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study. Clin. Exp. Rheumatol. 4: 129-134 (1986).

• Molino G, Hofmann AF, Cravetto C, Belforte G, Bona B. Simulation of the metabolism and enterohepatic circulation of endogenous chenodeoxycholic acid in man using a physiological pharmacokinetic model. Eur. J. Clin. Invest. 16: 397-414 (1986).

• Moon RC, Mehta RG. Anticarcinogenic effects of retinoids in animals. Adv. Exp. Med. Biol. 206: 399-411 (1986).

• Morell A, Muehlheim E, Schaad U, Skvaril F, Rossi E. Susceptibility to infections in children with selective IgA- and IgA-IgG subclass deficiency. Eur. J. Pediatr. 145: 199-203 (1986).

• Morl M. Are there new aspects in the therapy of primary biliary cirrhosis? Leber. Magen. Darm. 16: 338-343 (1986).

• Mouritsen S, Demant E, Permin H, Wiik A. High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases. Clin. Exp. Immunol. 66: 68-76 (1986). *

• Muller JY, Clemenceau S, Foncin JF, Salmon D, Halle L, Castellano F, Salmon C. Absence of linkage between Alzheimer's disease and the HLA system. C. R. Acad. Sci. III. 303: 105-108 (1986).

• Munford RS, Hall CL. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234: 203-205 (1986). *

• Munro R, Sorrell TC. Biliary sepsis. Reviewing treatment options. Drugs 31: 449-454 (1986).

• Nagafuchi Y, Scheuer PJ. Hepatic beta 2-microglobulin distribution in primary biliary cirrhosis. J. Hepatol. 2: 73-80 (1986).

• Nakanuma Y, Hirai N, Kono N, Ohta G. Histological and ultrastructural examination of the intrahepatic biliary tree in primary sclerosing cholangitis. Liver 6: 317-325 (1986).

• Nakanuma Y, Nakamura Y, Hoso M, Ohta G. Atrophy and ductopenia of the right hepatic lobe in a patient with choledocholithiasis. Acta Pathol. Jpn. 36: 1719-1726 (1986).

• Nakanuma Y, Ohta G. Immunohistochemical study on bile ductular proliferation in various hepatobiliary diseases. Liver 6: 205-211 (1986).

• Nepom GT, Seyfried CA, Nepom BS. Immunogenetics of disease susceptibility: new perspectives in HLA. Pathol. Immunopathol. Res. 5: 37-46 (1986).

• Neuberger J. Primary biliary cirrhosis. Dig. Dis. 4: 162-177 (1986).

• Neuberger J, Altman DG, Christensen E, Tygstrup N, Williams R. Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation 41: 713-716 (1986).

• Nolan JP, DeLissio MG, Camara DS, Feind DM, Gagliardi NC. IgA antibody to lipid A in alcoholic liver disease. Lancet 1: 176-179 (1986).

• Nuutinen HU. Activities of ethanol-metabolizing enzymes in liver diseases. Scand. J. Gastroenterol. 21: 678-684 (1986).

• Oelberg DG, Lester R. Cellular mechanisms of cholestasis. Annu. Rev. Med. 37: 297-317 (1986). *

• Ohuchi N, Ohi R, Takahashi T, Kasai M. Postoperative changes of intrahepatic portal veins in biliary atresia - a 3-D reconstruction study. J. Pediatr. Surg. 21: 10-14 (1986).

• Ojeda VJ, Levitt S, Ryan G, Laurence BH. Cystic fibrosis, Crohn's colitis, and adult meconium ileus equivalent. Dis. Colon Rectum 29: 567-571 (1986).

• Oliviero S, DeMarchi M, Bast BJ, Zegers BJ, van Loghem E, de Lange G, Carbonara O. Molecular analysis of a case of IgA2 deficiency. J. Immunogenet. 13: 3-9 (1986).

• Ollier W, Silman A, Gosnell N, Currey H, Awad J, Doyle P, McCloskey D, Alonso A, Hossain MA, Festenstein H. HLA and rheumatoid arthritis: an analysis of multicase families. Dis. Markers 4: 85-98 (1986).

• Ozsoylu S, Kocak N, Buyukpamukcu N, Gogus S, Besim A. Sclerosing cholangitis in a six-year-old boy. Turk. J. Pediatr. 28: 271-277 (1986).

• Papasteriades C, Spiliadis C, Emmanouilidis A, Papadimitriou C, Economidou J, Manousos O. Histocompatibility antigens (HLA-A, B) and ulcerative colitis in a Greek population. Digestion 33: 229-232 (1986).

• Paronetto F. Cell-mediated immunity in liver disease. Hum. Pathol. 17: 168-178 (1986).

• Peeters GJ, Cremers CW, Pinckers AJ, Hoefnagels WH. Atypical Cogan's syndrome: an autoimmune disease? Ann. Otol. Rhinol. Laryngol. 95: 173-175 (1986).

• Pelkonen O. Host susceptibility in organic solvent toxicity. Prog. Clin. Biol. Res. 220: 107-114 (1986).

• Penner E. Demonstration of immune complexes containing the ribonucleoprotein antigen Ro in primary biliary cirrhosis. Gastroenterology 90: 724-727 (1986).

• Penner E, Goldenberg H, Meryn S, Gordon J. A dot-immunobinding assay for antimitochondrial antibodies. Hepatology 6: 381-384 (1986).

• Penner E, Kindas-Mugge I, Hitchman E, Sauermann G. Nuclear antigens recognized by antibodies present in liver disease sera. Clin. Exp. Immunol. 63: 428-433 (1986). *

• Peskar BM, Dreyling KW, Peskar BA, May B, Goebell H. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid. Agents Actions 18: 381-383 (1986).

• Petty RE, Malleson P. Spondyloarthropathies of childhood. Pediatr. Clin. North Am. 33: 1079-1096 (1986).

• Petty RE, Sherry DD, Johannson JM. IgG anti-IgA1 and anti-IgA2 antibodies: their measurement by an enzyme-linked immunosorbent assay and their relationship to disease. Int. Arch. Allergy Appl. Immunol. 80: 337-341 (1986).

• Pike JW, Allegretto EA, Kelly MA, Donaldson CA, Marion SL, Mangelsdorf DJ, Haussler MR. 1,25-Dihydroxyvitamin D3 receptors: altered functional domains are associated with cellular resistance to vitamin D3. Adv. Exp. Med. Biol. 196: 377-390 (1986).

• Polokoff MA, Everson GT. Hepatocyte-hepatoma cell hybrids. Characterization and demonstration of bile acid synthesis. J. Biol. Chem. 261: 4085-4089 (1986). *

• Popov MS, Popova IV. Primary biliary cirrhosis of the liver. Arkh. Patol. 48: 81-87 (1986).

• Poulsen LO, Elling P, Sorensen FB, Hoedt-Rasmussen K. HLA-DR expression and disease activity in ulcerative colitis. Scand. J. Gastroenterol. 21: 364-368 (1986).

• Powell-Tuck J. Protein metabolism in inflammatory bowel disease. Gut 27 Suppl. 1: 67-71 (1986). *

• Prakash S, Singh K, Malik AK, Kataria S, Vora IM, Naik SR. Primary sclerosing cholangitis associated with chronic idiopathic ulcerative colitis. Indian J. Gastroenterol. 5: 205-207 (1986).

• Puengtomwatanakul S, Sirisinha S. Impaired biliary secretion of immunoglobulin A in vitamin A-deficient rats. Proc. Soc. Exp. Biol. Med. 182: 437-442 (1986).

• Purrmann J, Miller B, Strohmeyer G. Etiology of chronic inflammatory bowel diseases. Z. Gastroenterol. 24: 357-363 (1986).

• Puttick A, Briggs D, Welsh K, Jacoby R, Williamson E, Jones V. Extended haplotypes in rheumatoid arthritis and preliminary evidence for an interaction with immunoglobulin genes. Dis. Markers 4: 139-144 (1986).

• Raedler A, Bredow G, Kirch W, Thiele HG, Greten H. In vivo activated peripheral T cells in autoimmune disease. J. Clin. Lab. Immunol. 19: 181-186 (1986).

• Rocklin RE, Maxwell NR, Thistle L, Kaplan MM. In vitro anti-mitochondrial antibody synthesis in patients with primary biliary cirrhosis. Clin. Immunol. Immunopathol. 38: 22-31 (1986).

• Rodes J, Pares A. Primary biliary cirrhosis, a multisystemic disease? Med. Clin. (Barc.) 87: 285-287 (1986).

• Roediger W, Schapel G, Lawson M, Radcliffe B, Nance S. Effect of 5-aminosalicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa. Pharmacological implications for ulcerative colitis. Biochem. Pharmacol. 35: 221-225 (1986).

• Roediger WE, Lawson MJ, Nance SH, Radcliffe BC. Detectable colonic nitrite levels in inflammatory bowel disease - mucosal or bacterial malfunction? Digestion 35: 199-204 (1986).

• Romeo G, Devoto M, Bianco M. Homogeneity vs. heterogeneity of cystic fibrosis in Italy. Am. J. Hum. Genet. 39: 283-284 (1986). *

• Rotter JI, Vadheim CM, Petersen GM, Cantor RM, Riley WJ, Maclaren NK. HLA haplotype sharing and proband genotype in IDDM. Genet. Epidemiol. Suppl. 1: 347-352 (1986).

• Rouisse L, Chakrabarti SK. Dose-dependent metabolism of trichloroethylene and its relevance to hepatotoxicity in rats. Environ. Res. 40: 450-458 (1986).

• Roujeau JC, Bracq C, Huyn NT, Chaussalet E, Raffin C, Duedari N. HLA phenotypes and bullous cutaneous reactions to drugs. Tissue Antigens 28: 251-254 (1986).

• Rutan G, Martinez AJ, Fieshko JT, Van Thiel DH. Primary biliary cirrhosis, Sjogren's syndrome, and transverse myelitis. Gastroenterology 90: 206-210 (1986).

• Rychlikova M, Hinzova E, Nosek J, Forejt J. Supertypic HLA-Bw4 antigen detected by a new monoclonal antibody. Exp. Clin. Immunogenet. 3: 88-97 (1986).

• Saari KM, Kaarela K, Korpela T, Laippala P, Frants RR, Eriksson AW. Alpha 1-antitrypsin in acute anterior uveitis and rheumatic diseases. Acta Ophthalmol. (Copenh.) 64: 522-529 (1986).

• Sakagami Y, Mizoguchi Y, Miyajima K, Tsutsui H, Takeda H, Shin T, Shindo Y, Higashimori T, Seki S, Harihara S, et al. Intrahepatic cholestasis induced by heat-killed Propionibacterium acnes in the tuberculin-sensitized guinea pig. Nippon Shokakibyo Gakkai Zasshi 83: 1318-1323 (1986).

• Sandler RS, Golden AL. Epidemiology of Crohn's disease. J. Clin. Gastroenterol. 8: 160-165 (1986).

• Satoh Y, Ishikawa K, Tanaka H, Ono K. Immunohistochemical observations of immunoglobulin A in the Paneth cells of germ-free and formerly-germ-free rats. Histochemistry 85: 197-201 (1986).

• Saxena S, Nouri-Aria KT, Anderson MG, Eddleston AL, Williams R. Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon. Clin. Exp. Immunol. 63: 541-548 (1986). *

• Sayetta RB. Theories of the etiology of multiple sclerosis: a critical review. J. Clin. Lab. Immunol. 21: 55-70 (1986).

• Schiff JM, Fisher MM, Jones AL, Underdown BJ. Human IgA as a heterovalent ligand: switching from the asialoglycoprotein receptor to secretory component during transport across the rat hepatocyte. J. Cell Biol. 102: 920-931 (1986). *

• Schillinger F, Montagnac R, Milcent T. A new case of severe allopurinol toxicity. Nephrologie 7: 214 (1986).

• Scholmerich J, Gerok W. Drug therapy of chronic inflammatory intestinal diseases - current status of 5-aminosalicylic acid. Wien. Klin. Wochenschr. 98: 762-769 (1986).

• Scudeletti M, Indiveri F, Pierri I, Picciotto A, Ferrone S. T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions. Cell. Immunol. 102: 227-233 (1986).

• Sculley TB, Pope JH, Hazelton RA. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis. Arthritis Rheum. 29: 964-970 (1986).

• Seetharam S, Sussman NL, Komoda T, Alpers DH. The mechanism of elevated alkaline phosphatase activity after bile duct ligation in the rat. Hepatology 6: 374-380 (1986).

• Segawa K, Nakazawa S, Tsukamoto Y, Yamaguchi H, Goto H, Kurita Y. Determination of plasma retinol by high performance liquid chromatography, and its significance in digestive diseases. Jpn. J. Med. 25: 20-24 (1986). *

• Seki S, Matsui T, Nakajima S, Kawai K, Monna T, Yamamoto S. Production of histological changes mimicking primary biliary cirrhosis in rabbits by immunization with bile duct antigen. Gastroenterol. Jpn. 21: 349-356 (1986).

• Seki S, Tanaka K, Fujisawa M, Shiomi S, Saitoh S, Sakagami Y, Matsui T, Mizoguchi Y, Kuroki T, Harihara S, et al. A patient with asymptomatic primary biliary cirrhosis in association with Sjogren syndrome developing features of systemic lupus erythematosus. Nippon Shokakibyo Gakkai Zasshi 83: 2445-2449 (1986).

• Sevenet F, Capron JP. Asymptomatic forms of primary biliary cirrhosis seen in 10 years in Picardie. Presse. Med. 15: 1957-1960 (1986).

• Shaffer JL, Kershaw A, Houston JB. Disposition of metronidazole and its effects on sulphasalazine metabolism in patients with inflammatory bowel disease. Br. J. Clin. Pharmacol. 21: 431-435 (1986).

• Sherlock S. The spectrum of hepatotoxicity due to drugs. Lancet 2: 440-444 (1986).

• Sherlock S, Epstein O. Primary biliary cirrhosis. The present position. Ann. N. Y. Acad. Sci. 465: 378-385 (1986). *

• Shimizu M, Yuh K, Aoyama S, Ichihara I, Watanabe H, Shijo H, Okumura M. Immunohistochemical characterization of inflammatory infiltrates at the site of bile duct injury in primary biliary cirrhosis. Liver 6: 1-6 (1986).

• Shuckett R, Russell ML, Gladman DD. Atypical erosive osteoarthritis and Sjogren's syndrome. Ann. Rheum. Dis. 45: 281-288 (1986). *

• Siciliano M, Milani A, Marra L, Arringoli D, Rossi L. Serum bile acids in cirrhosis: correlation with liver function parameters and with the severity of the disease. Quad. Sclavo. Diagn. 22: 355-361 (1986).

• Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum. 29: 82-87 (1986).

• Singh B, Milton JD, Woodrow JC. Ankylosing spondylitis, HLA-B27, and Klebsiella: a study of lymphocyte reactivity of anti-Klebsiella sera. Ann. Rheum. Dis. 45: 190-197 (1986). *

• Skanes VM, Barnard J, Farid N, Marshall WH, Murphy L, Rideout D, Taylor R, Xidos G, Larsen B. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis. Mol. Biol. Med. 3: 143-157 (1986).

• Smith ND, Boyer JL. Are antimitochondrial antibodies of prognostic value in primary biliary cirrhosis? Hepatology 6: 739-741 (1986).

• Spencer J, Finn T, Isaacson PG. Human Peyer's patches: an immunohistochemical study. Gut 27: 405-410 (1986). *

• Spencer J, Finn T, Isaacson PG. A comparative study of the gut-associated lymphoid tissue of primates and rodents. Virchows Arch. B. Cell. Pathol. Incl. Mol. Pathol. 51: 509-519 (1986).

• Stellon AJ, Webb A, Compston J, Williams R. Lack of osteomalacia in chronic cholestatic liver disease. Bone 7: 181-185 (1986).

• Stellon AJ, Williams R. Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br. Med. J. (Clin. Res. Ed.) 293: 297-298 (1986). *

• Stenszky V, Kozma L, Balazs C, Bear JC, Farid NR. The role of HLA antigens in the manifestation and course of Graves' disease. Mol. Biol. Med. 3: 53-62 (1986).

• Strothman R, White MB, Testin J, Chen SN, Ball MJ. HLA and IgA deficiency in blood donors. Hum. Immunol. 16: 289-294 (1986).

• Su WP, Schroeter AL, Perry HO, Powell FC. Histopathologic and immunopathologic study of pyoderma gangrenosum. J. Cutan. Pathol. 13: 323-330 (1986).

• Suarez-Almazor ME, Russell AS, LeClercq S. Ankylosing spondylitis in families with two distinct B27 haplotypes: a selective association. Arthritis Rheum. 29: 1510-1514 (1986).

• Suyama Y, Murawaki Y, Horie Y, Hirayama C, Kanbe N, Takenaka M, Shimao S, Ohta G. A case of primary biliary cirrhosis associated with generalized morphea. Hepatogastroenterology 33: 199-200 (1986).

• Suzuki I, Kitamura K, Kiyono H, Kurita T, Green DR, McGhee JR. Isotype-specific immunoregulation. Evidence for a distinct subset of T contrasuppressor cells for IgA responses in murine Peyer's patches. J. Exp. Med. 164: 501-516 (1986). *

• Taggart AJ, Neumann VC, Hill J, Astbury C, Le Gallez P, Dixon JS. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis? Drugs 32 Suppl. 1: 27-34 (1986).

• Tait BD, Propert DN, Harrison L, Mandel T, Martin FI. Interaction between HLA antigens and immunoglobulin (Gm) allotypes in susceptibility to type I diabetes. Tissue Antigens 27: 249-255 (1986).

• Takikawa H, Stolz A, Kaplowitz N. Purification of a 32.5 kDa monomeric sulfotransferase from rat liver with activity for bile acids and phenolic steroids. FEBS Lett. 207: 193-197 (1986). *

• Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clin. Proc. 61: 140-145 (1986).

• Tanaka K, Shimada M, Sasahara A, Yamamoto H, Naruto T, Tomida Y. Chronic hepatitis associated with Epstein-Barr virus infection in an infant. J. Pediatr. Gastroenterol. Nutr. 5: 467-471 (1986).

• Tanaka M, Umihara J, Chiba S, Ishikawa E. Intrahepatic bile duct injury following bone marrow transplantation. Analysis of pathological features based on three-dimensional and histochemical observation. Acta Pathol. Jpn. 36: 1793-1806 (1986).

• Teufel M, Luik G, Niessen KH. Gastrin, secretin, VIP and motilin in children with mucoviscidosis and Crohn disease. Monatsschr. Kinderheilkd. 134: 132-137 (1986).

• Thompson JN, Cohen J, Blenkharn JI, McConnell JS, Barr J, Blumgart LH. A randomized clinical trial of oral ursodeoxycholic acid in obstructive jaundice. Br. J. Surg. 73: 634-636 (1986).

• Thomson W, Dyer PA, Sanders PA, Grennan DM. C3, Gm, and Pi polymorphisms in rheumatoid arthritis. Dis. Markers 4: 145-150 (1986).

• Torfs CP, King MC, Huey B, Malmgren J, Grumet FC. Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am. J. Hum. Genet. 38: 170-187 (1986). *

• Tsianos EB, Jalali MT, Gowenlock AH, Braganza JM. Serum isoamylases in liver diseases. Hepatogastroenterology 33: 247-249 (1986).

• Uddenfeldt P, Danielsson A. Evaluation of rheumatic disorders in patients with primary biliary cirrhosis. Ann. Clin. Res. 18: 148-153 (1986).

• Upfold LI, Sullivan JS, Geczy AF. Biochemical studies on a factor isolated from Klebsiella K43-BTS1 that cross-reacts with cells from HLA-B27 positive patients with ankylosing spondylitis. Hum. Immunol. 17: 224-238 (1986).

• Van Dyke TE, Dowell VR Jr, Offenbacher S, Snyder W, Hersh T. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect. Immun. 53: 671-677 (1986). *

• Vanderstigel M, Zafrani ES, Lejonc JL, Schaeffer A, Portos JL. Allopurinol hypersensitivity syndrome as a cause of hepatic fibrin-ring granulomas. Gastroenterology 90: 188-190 (1986).

• Vento S, O'Brien CJ, McFarlane BM, McFarlane IG, Eddleston AL, Williams R. T-lymphocyte sensitization to hepatocyte antigens in autoimmune chronic active hepatitis and primary biliary cirrhosis. Evidence for different underlying mechanisms and different antigenic determinants as targets. Gastroenterology 91: 810-817 (1986).

• Versapuech JM, Labayle D, Grange D, Fischer D, Kemeny F, D'Hubert E. Sclerosing cholangitis, chronic pancreatitis and Sjogren's syndrome. Ann. Med. Interne. (Paris) 137: 147-151 (1986).

• Vessey M, Jewell D, Smith A, Yeates D, McPherson K. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. Br. Med. J. (Clin. Res. Ed.) 292: 1101-1103 (1986). *

• Vogel W, Fagan EA, Bomford A, Portmann B, Williams R. Wash off liver cytology: a complementary diagnostic tool to liver biopsy. J. Clin. Pathol. 39: 449-452 (1986). *

• Wakefield D, Easter J, Robinson P, Graham D, Penny R. Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA B27. Clin. Exp. Immunol. 63: 49-57 (1986). *

• Walker DJ, Griffiths ID. HLA associations are with severe rheumatoid arthritis. Dis. Markers 4: 121-132 (1986).

• Walker DJ, Griffiths M, Griffiths ID. Occurrence of autoimmune diseases and autoantibodies in multicase rheumatoid arthritis families. Ann. Rheum. Dis. 45: 323-326 (1986). *

• Wallaert B, Bonniere P, Prin L, Cortot A, Tonnel AB, Voisin C. Primary biliary cirrhosis. Subclinical inflammatory alveolitis in patients with normal chest roentgenograms. Chest 90: 842-848 (1986). *

• Watkinson G. Sulphasalazine: a review of 40 years' experience. Drugs 32 Suppl. 1: 1-11 (1986).

• Weber P, Brenner J, Stechemesser E, Klein R, Weckenmann U, Kloppel G, Kirchhof M, Fintelmann V, Berg PA. Characterization and clinical relevance of a new complement-fixing antibody - anti-M8 - in patients with primary biliary cirrhosis. Hepatology 6: 553-559 (1986).

• Weiss MJ, Henthorn PS, Lafferty MA, Slaughter C, Raducha M, Harris H. Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc. Natl. Acad. Sci. U.S.A. 83: 7182-7186 (1986). *

• Welch TR, Beischel L, Balakrishnan K, Quinlan M, West CD. Major-histocompatibility-complex extended haplotypes in membranoproliferative glomerulonephritis. N. Engl. J. Med. 314: 1476-1481 (1986).

• Wiesner RH. Does propranolol precipitate hepatic encephalopathy? J. Clin. Gastroenterol. 8: 74-76 (1986).

• Willems B, Villeneuve JP, Huet PM. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation. Hepatology 6: 92-97 (1986).

• Williams JW, Vera SR, Peters TG, Van Voorst S. Survival following hepatic transplantation in the cyclosporine era. Am. Surg. 52: 291-293 (1986).

• Wood JR, Czaja AJ, Beaver SJ, Hall S, Ginsburg WW, Kaufman DK, Markowitz H. Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis. Hepatology 6: 976-980 (1986).

• Woodrow JC. Analysis of the HLA association with rheumatoid arthritis. Dis. Markers 4: 7-12 (1986).

• Yamada G, Hyodo I, Tobe K, Mizuno M, Nishihara T, Kobayashi T, Nagashima H. Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology 6: 385-391 (1986).

• Yamashita TS, Khan MA, Kushner I. Genetic analysis of families with multiple cases of rheumatoid arthritis. Dis. Markers 4: 113-119 (1986).

• Yoon YB, Hagey LR, Hofmann AF, Gurantz D, Michelotti EL, Steinbach JH. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents. Gastroenterology 90: 837-852 (1986).

• Zegers BJ, van Loghem E, Out T, Schuurman HJ, Bast EJ, de Lange G, Kater L. Familial deficiency of immunoglobulin IgA2. Monogr. Allergy 20: 195-202 (1986).

• Zeisel SH, DaCosta KA. Increase in human exposure to methylamine precursors of N-nitrosamines after eating fish. Cancer Res. 46: 6136-6138 (1986). *

• Zemskov VS, Shor-Chudnovskii ME, Makeev AF. Classification of forms of cholangitis. Klin. Khir. 9: 17-20 (1986).

Number of references = 292

www psc-literature.org